Thursday, December 07, 2017 8:19:32 AM
All told, 80 Institutional owners comprising 11 million shares of the 30 million outstanding.
Bunch of November 14 & 15 filings- some of the more notable increases in either percentage or number of shares acquired:
Morgan Stanley discloses a 286.04% increase in shares of CNAT / Conatus Pharmaceuticals Inc.- Morgan Stanley has filed a 13F-HR form disclosing ownership of 326,531 shares of Conatus Pharmaceuticals Inc.
Vanguard Group Inc discloses a 20.74% increase in shares of CNAT / Conatus Pharmaceuticals Inc.-Vanguard Group Inc has filed a 13F-HR form disclosing ownership of 1,215,678 shares of Conatus Pharmaceuticals Inc.
Aqr Capital Management Llc discloses a 900.83% increase in shares of CNAT / Conatus Pharmaceuticals Inc.-Aqr Capital Management Llc has filed a 13F-HR form disclosing ownership of 324,939 shares of Conatus Pharmaceuticals Inc.
Geode Capital Management, Llc discloses a 41.03% increase in shares of CNAT / Conatus Pharmaceuticals Inc.-Geode Capital Management, Llc has filed a 13F-HR form disclosing ownership of 340,377 shares of Conatus Pharmaceuticals Inc.
BlackRock Inc. discloses a 2.32% increase in shares of CNAT / Conatus Pharmaceuticals Inc.- BlackRock Inc. has filed a 13F-HR form disclosing ownership of 1,500,380 shares of Conatus Pharmaceuticals Inc.
State Street Corp discloses a 2.56% increase in shares of CNAT / Conatus Pharmaceuticals Inc.-State Street Corp has filed a 13F-HR form disclosing ownership of 372,111 shares of Conatus Pharmaceuticals Inc.
United Capital Financial Advisers, Llc discloses a 69.17% increase in shares of CNAT / Conatus Pharmaceuticals Inc-United Capital Financial Advisers, Llc has filed a 13F-HR form disclosing ownership of 329,521 shares of Conatus Pharmaceuticals Inc.
There are, in addition, several small hedge funds who sold/closed out small positions as well.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM